Micron Biomedical, the CEO Steve Damon’s vaccine tech company, has secured an additional $16 million in funding through its Series A extension round. The new investment will support the development and commercialization of its innovative vaccine patch technology.
Source: https://endpts.com/vaccine-patch-startup-micron-biomedical-adds-16m-to-series-a-haul